Journal
CANCER RESEARCH
Volume 75, Issue 20, Pages 4335-4350Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-14-3426
Keywords
-
Categories
Funding
- Institut National de la Sante Et de la Recherche Medicale (INSERM Avenir program)
- Association pour la Recherche sur le Cancer
- Ministere de l'Enseignement Superieur et de la Recherche of France
- Ligue Nationale Contre le Cancer
- Ecole Normale Superieure of Lyon
Ask authors/readers for more resources
The transcription accessory factor TIF1 gamma/TRIM33/RFG7/PTC7/ Ectodermin functions as a tumor suppressor that promotes development and cellular differentiation. However, its precise function in cancer has been elusive. In the present study, we report that TIF1 gamma inactivation causes cells to accumulate chromosomal defects, a hallmark of cancer, due to attenuations in the spindle assembly checkpoint and the post-mitotic checkpoint. TIF1 gamma deficiency also caused a loss of contact growth inhibition and increased anchorage-independent growth in vitro and in vivo. Clinically, reduced TIF1 gamma expression in human tumors correlated with an increased rate of genomic rearrangements. Overall, our work indicates that TIF1 gamma exerts its tumor-suppressive functions in part by promoting chromosomal stability. (C) 2015 AACR.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available